Drug intelligence / Profile preview

ectoin (bitop AG)

Development stage
Unknown
Lead developer
Bitop
Modality
Small Molecules
Administration
Topical
01

Overview

Ectoin is a naturally occurring extremolyte, a small organic molecule produced by halophilic bacteria to survive extreme environmental conditions. In topical emollient formulations, ectoin acts as a compatible solute that binds water molecules to create a stable, protective hydration shell (the Ectoin Hydro Complex) around proteins and lipid bilayers. This physical mechanism stabilizes the skin barrier, reduces transepidermal water loss (TEWL), and protects cells from environmental stressors and allergens. It is used as a non-steroidal treatment for inflammatory skin conditions such as atopic dermatitis, eczema, and psoriasis, providing anti-inflammatory effects and symptom relief (redness, pruritus) comparable to mild corticosteroids in some studies. Ectoin-containing emollients are often classified as medical devices in the European Union.

Brand names
ZarzendaEctoin Dermatitis CreamSanadermil EctoinDermaEctoinEcto-Derm
Other names
ectoine1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acidectoin emollient

Beyond the preview

Go deeper on ectoin (bitop AG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ectoin (bitop AG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call